Relationship between CHA2DS2-VASc score and atrial electromechanical function in patients with paroxysmal atrial fibrillation: A pilot study

Journal of Cardiology

Volumn 66, Issue 5, 2015, Pages 382-387

  Vatan, Mehmet Bülent ^a   Yilmaz, Sabiye ^a   Ağaç, Mustafa Tarik ^a   Çakar, Mehmet Akif ^a   Erkan, Hakan ^b   Aksoy, Murat ^a   Demirtas, Saadet ^a   Varim, Ceyhun ^a   Akdemir, Ramazan ^a   Gündüz, Hüseyin ^a  

^a SAKARYA UNIVERSITY   (Turkey)

^b Trabzon Ahi Evren Thorasic and Cardiovascular Surgery Training and Research Hospital   (Turkey)

Author keywords

Atrial fibrillation; Echocardiography; Remodeling; Risk stratification

Indexed keywords

ADULT; ARTICLE; ATRIAL ELECTROMECHANICAL FUNCTION; ATRIAL FIBRILLATION; CARDIAC PATIENT; CHA2DS2 VASC SCORE; FEMALE; HEART ATRIUM FUNCTION; HEART ATRIUM REMODELING; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; LEFT ATRIUM ACTIVE EMPTYING VOLUME; LEFT ATRIUM PASSIVE EMPTYING VOLUME; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PILOT STUDY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TISSUE DOPPLER IMAGING; AGED; COMPLICATION; ECHOCARDIOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STROKE;

ADULT; AGED; ATRIAL FIBRILLATION; ATRIAL FUNCTION, LEFT; ATRIAL REMODELING; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; RISK ASSESSMENT; ROC CURVE; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84943663776     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2015.02.009     Document Type: Article

References (35)

1. Page R.L. Clinical practice. Newly diagnosed atrial fibrillation. N Engl J Med 2004, 351:2408-2416.
2. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation 1991, 84:527-539. Stroke Prevention in Atrial Fibrillation Investigators.
3. Inoue H., Atarashi H., Okumura K., Yamashita T., Kumagai N., Origasa H. Thromboembolic events in paroxysmal vs. permanent non-valvular atrial fibrillation: subanalysis of the J-RHYTHM Registry. Circ J 2014, 78:2388-2393.
4. Lip G.Y., Nieuwlaat R., Pisters R., Lane D.A., Crijns H.J. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010, 137:263-272.
5. Komatsu T., Tachibana H., Satoh Y., Ozawa M., Kunugita F., Ueda H., Nakamura M. Relationship between CHA(2)DS(2)-VASc scores and ischemic stroke/cardiovascular events in Japanese patients with paroxysmal atrial fibrillation not receiving anticoagulant therapy. J Cardiol 2012, 59:321-328.
6. Camm A.J., Kirchhof P., Lip G.Y., Schotten U., Savelieva I., Ernst S., Gelder I., Al-Attar N., Hindricks G., Prendergast B., Heidbuchel H., Alfieri O., Angelini A., Atar D., Colonna P., et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010, 31:2369-2429.
7. Cohen M., Naccarelli G.V. Pathophysiology and disease progression of atrial fibrillation: importance of achieving and maintaining sinus rhythm. J Cardiovasc Electrophysiol 2008, 19:885-890.
8. Fujino T., Takahashi A., Kuwahara T., Takahashi Y., Okubo K., Takigawa M., Ikeda T. Assessment of clinical factors associated with a successful catheter ablation outcome in younger patients with atrial fibrillation. J Cardiol 2014, 63:438-443.
9. Allessie M., Ausma J., Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002, 54:230-246.
10. Kostin S., Klein G., Szalay Z., Hein S., Bauer E.P., Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002, 54:361-379.
11. Nakai T., Chandy J., Nakai K., Bellows W.H., Flachsbart K., Lee R.J., Leung J.M. Histologic assessment of right atrial appendage myocardium in patients with atrial fibrillation after coronary artery bypass graft surgery. Cardiology 2007, 108:90-96.
12. Goette A., Bukowska A., Lendeckel U., Erxleben M., Hammwohner M., Strugala D., Pfeiffenberger J., Röhl F.W., Huth C., Ebert M., Klein H.U., Röcken C. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression. Circulation 2008, 117:732-742.
13. Deniz A., Sahiner L., Aytemir K., Kaya B., Kabakci G., Tokgozoglu L., Oto A. Tissue Doppler echocardiography can be a useful technique to evaluate atrial conduction time. Cardiol J 2012, 19:487-493.
14. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989, 2:358-367.
15. Devereux R.B. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension 1987, 9:9-26.
16. Xu J., Cui G., Esmailian F., Plunkett M., Marelli D., Ardehali A., Odim J., Laks H., Sen L. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 2004, 109:363-368.
17. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., Solomon S.D., Spencer K.T., Sutton M.J., Stewart W.J. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
18. Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: the Stroke Prevention in Atrial Fibrillation Study. J Stroke Cerebrovasc Dis 1995, 4:147-157. Stroke Prevention in Atrial Fibrillation Investigators.
19. Lester S.J., Ryan E.W., Schiller N.B., Foster E. Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol 1999, 84:829-832.
20. Spach M.S., Heidlage J.F., Dolber P.C., Barr R.C. Mechanism of origin of conduction disturbances in aging human atrial bundles: experimental and model study. Heart Rhythm 2007, 4:175-185.
21. Rosca M., Lancellotti P., Popescu B.A., Pierard L.A. Left atrial function: pathophysiology, echocardiographic assessment, and clinical applications. Heart 2011, 97:1982-1989.
22. Gerdts E., Wachtell K., Omvik P., Otterstad J.E., Oikarinen L., Boman K., Dahlöf B., Devereux R.B. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial. Hypertension 2007, 49:311-316.
23. Kleemann T., Becker T., Strauss M., Schneider S., Seidl K. Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score. Eur J Echocardiogr 2009, 10:383-388.
24. Toh N., Kanzaki H., Nakatani S., Ohara T., Kim J., Kusano K.F., Hashimura K., Ohe T., Ito H., Kitakaze M. Left atrial volume combined with atrial pump function identifies hypertensive patients with a history of paroxysmal atrial fibrillation. Hypertension 2010, 55:1150-1156.
25. Murphy N.F., Simpson C.R., Jhund P.S., Stewart S., Kirkpatrick M., Chalmers J., MacIntyre K., McMurray J.J. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart 2007, 93:606-612.
26. Rutter M.K., Parise H., Benjamin E.J., Levy D., Larson M.G., Meigs J.B., Nesto R.W., Wilson P.W., Vasan R.S. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 2003, 107:448-454.
27. Abhayaratna W.P., Seward J.B., Appleton C.P., Douglas P.S., Oh J.K., Tajik A.J., Tsang T.S. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol 2006, 47:2357-2363.
28. Illien S., Järvinen S., Recke G., Hammerstingl C., Schmidt H., Kuntz-Hehner S., Lüderitz B., Omran H. Atrial fibrillation: relation between clinical risk factors and transoesophageal echocardiographic risk factors for thromboembolism. Heart 2003, 89:165-168.
29. Providência R., Botelho A., Trigo J., Quintal N., Nascimento J., Mota P., Leitão-Marques A. Possible refinement of clinical thromboembolism assessment in patients with atrial fibrillation using echocardiographic parameters. Europace 2012, 14:36-45.
30. Park J.H., Joung B., Son N.H., Shim J.M., Lee M.H., Hwang C., Pak H.N. The electroanatomical remodelling of the left atrium is related to CHADS2/CHA2DS2VASc score and events of stroke in patients with atrial fibrillation. Europace 2011, 13:1541-1549.
31. Chao T.F., Lin Y.J., Tsao H.M., Chang S.L., Lo L.W., Hu Y.F., Tuan T.C., Li C.H., Chang H.Y., Wu T.J., Yu W.C., Chen S.A. Prolonged atrium electromechanical interval is associated with stroke in patients with atrial fibrillation after catheter ablation. J Cardiovasc Electrophysiol 2013, 24:375-380.
32. Chao T.F., Sung S.H., Wang K.L., Tsao H.M., Lin Y.J., Chang S.L., Lo L.W., Hu Y.F., Tuan T.C., Suenari K., Li C.H., Liu S.H., Wu T.J., Yu W.C., Chen S.A. Atrial electromechanical interval can identify patients with paroxysmal atrial fibrillation and is associated with CHADS2 score and peak velocity of left atrial appendage. J Cardiovasc Electrophysiol 2011, 22:1325-1330.
33. Nattel S., Burstein B., Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol 2008, 1:62-73.
34. Li Y., Ding W., Wang H., Song N., Lin L., Wang Z., Zhong M., Zhang Y., Zhang W. Relationship of CHA2DS2-VASc and CHADS2 score to left atrial remodeling detected by velocity vector imaging in patients with atrial fibrillation. PLOS ONE 2013, 8:e77653.
35. Camm J., Lip G., Caterina R., Savelieva I., Atar D., Hohnloser S.H., Hindricks G., Kirchhof 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2012, 33:2719-2747.